Development of a Gastro-retentive Dosage Form of a New Promising Anti-tuberculosis Drug Macozinone

Introduction. Due to increase in the frequency of detecting cases of tuberculosis caused by strains of mycobacteria with resistance not only to traditional, but also recently introduced into clinical circulation anti-tuberculosis drugs, it is urgent to search for and develop new drugs that can be ef...

ver descrição completa

Detalhes bibliográficos

Principais autores:	V. G. Nesterenko, R. N. Bolgarin, B. A. Rudoy, D. K. Salakhetdinov, Yu. G. Kazaishvili, V. S. Scherbakova, N. A. Nikitina, Yu. V. Medvedev, E. N. Fisher, E. A. Malashenko, I. E. Shohin
Formato:	Artigo
Idioma:	Russo
Publicado em:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2021-08-01
coleção:	Разработка и регистрация лекарственных средств
Assuntos:	tuberculosis macozinone gastro-retentive tablet modified release mucoadhesion cyclodextrin
Acesso em linha:	https://www.pharmjournal.ru/jour/article/view/999
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!